Astria Therapeutics, Inc. (ATXS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 706K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 706K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 100% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 34.81M | 35.82M | 36.99M | 29.59M | 29.01M | 28.8M | 24.15M | 34.2M | 20.24M | 15.1M | 13.49M | 14.29M |
| OpEx % of Revenue | 4930.59% | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 10.66M | 9.88M | 9.21M | 9.66M | 8.5M | 8.09M | 8.42M | 7.42M | 6.9M | 6.01M | 5.46M | 5.19M |
| SG&A % of Revenue | 1510.06% | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 24.15M | 25.95M | 27.79M | 20.16M | 20.51M | 20.71M | 15.73M | 26.87M | 13.34M | 9.09M | 8.03M | 9.59M |
| R&D % of Revenue | 3420.54% | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | -231K | 0 | 0 | 0 | -91K | 0 | 0 | 0 | -487K |
| Operating Income | -34.1M | -35.82M | -36.99M | -29.59M | -29.01M | -28.8M | -24.15M | -34.2M | -20.24M | -15.1M | -13.49M | -14.29M |
| Operating Margin % | -4830.59% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -17.54% | -24.36% | -53.19% | 13.47% | -43.38% | -90.72% | -78.98% | -139.32% | -63.38% | -31.91% | 12.26% | -50.29% |
| EBITDA | -31.64M | -35.82M | -36.99M | -29.59M | -29.01M | -28.8M | -24.11M | -49.4M | -20.24M | -15.1M | -13.49M | -14.29M |
| EBITDA Margin % | -4482.01% | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -9.06% | -24.36% | -53.46% | 40.1% | -43.38% | -90.72% | -78.66% | -245.68% | -63.38% | -31.91% | 12.26% | -53.52% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 43.28K | -15.2M | 0 | 0 | 0 | 0 |
| EBIT | -31.64M | -35.82M | -36.99M | -29.59M | -29.01M | -28.8M | -24.15M | -19M | -20.24M | -15.1M | -13.49M | -14.29M |
| Net Interest Income | 2.5M | 2.89M | 3.35M | 3.96M | 4.52M | 4.65M | 4.24M | 2.8M | 2.53M | 2.56M | 2.32M | 1.02M |
| Interest Income | 2.5M | 2.89M | 3.35M | 3.96M | 4.52M | 4.65M | 4.24M | 2.8M | 2.53M | 2.56M | 2.32M | 1.02M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.46M | 2.77M | 3.29M | 3.96M | 4.48M | 4.63M | 4.22M | 2.79M | 2.51M | 2.54M | 2.31M | 1.03M |
| Pretax Income | -31.64M | -33.05M | -33.71M | -25.63M | -24.53M | -24.17M | -19.93M | -31.41M | -17.73M | -12.57M | -11.19M | -13.26M |
| Pretax Margin % | -4482.01% | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -31.64M | -33.05M | -33.71M | -25.63M | -24.53M | -24.17M | -19.93M | -31.41M | -17.73M | -12.57M | -11.19M | -13.26M |
| Net Margin % | -4482.01% | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -28.98% | -36.74% | -69.15% | 18.41% | -38.4% | -92.36% | -78.12% | -136.82% | -47.76% | -11.7% | 26.99% | -39.74% |
| Net Income (Continuing) | -31.64M | -33.05M | -33.71M | -25.63M | -24.53M | -24.17M | -19.93M | -31.41M | -17.73M | -12.57M | -11.19M | -13.26M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.55 | -0.57 | -0.58 | -0.45 | -0.43 | -0.43 | -0.38 | -0.86 | -0.63 | -0.45 | -0.40 | -0.66 |
| EPS Growth % | -27.91% | -32.56% | -52.63% | 47.67% | 31.75% | 4.44% | 5% | -30.3% | 27.59% | 47.67% | 65.81% | 10.81% |
| EPS (Basic) | -0.55 | -0.57 | -0.58 | -0.45 | -0.43 | -0.43 | -0.38 | -0.86 | -0.63 | -0.45 | -0.40 | -0.66 |
| Diluted Shares Outstanding | 58.01M | 58.01M | 58.01M | 56.43M | 56.49M | 56.49M | 52.29M | 36.52M | 28.04M | 28.02M | 27.94M | 18.42M |
| Basic Shares Outstanding | 58.01M | 58.01M | 58.01M | 56.43M | 56.49M | 56.49M | 52.29M | 36.52M | 28.04M | 28.02M | 27.94M | 18.42M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |